Keyword Connections

sars

Journals

27

1 accounts of chemical research

2 International journal of environmental research and public health

3 Cell

4 international immunopharmacology

5 Microbial pathogenesis

6 Nature

7 Journal of medical virology

8 diabetes & metabolic syndrome

9 emerging infectious diseases

10 Advances in therapy

11 clinical immunology (orlando, fla)

12 faseb journal : official publication of the federation of american societies for experimental biology

13 The FEBS Journal

14 Journal of the American Academy of Dermatology

15 the british journal of sociology

16 International Journal of Epidemiology

17 sichuan da xue xue bao yi xue ban = journal of sichuan university medical science edition

18 journal of the royal society of medicine

19 journal of thoracic oncology : official publication of the international association for the study of lung cancer

20 paediatric anaesthesia

21 new microbes and new infections

22 the journal of allergy and clinical immunology

23 anasthesiologie, intensivmedizin, notfallmedizin, schmerztherapie : ains

24 the journal of heredity

25 pathogens and global health

26 chembiochem : a european journal of chemical biology

27 zentralblatt fur bakteriologie, mikrobiologie und hygiene serie b, umwelthygiene, krankenhaushygiene, arbeitshygiene, praventive medizin

Research Groups

0

No Research Group Connected

Bibliographies

351

1 The uses of disorder in negotiated information orders: information leveraging and changing norms in global public health governance.

2 Hybrid Genome Evolution by Transposition: An Update.

3 Potential interventions for novel coronavirus in China: A systematic review.

4 Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV.

5 [Biological Product Development Strategies for Prevention and Treatment of Coronavirus Disease 2019].

6 Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids.

7 Use of Systemic Immunomodulatory Therapies During the Coronavirus Disease 2019 (COVID-19) Pandemic.

8 Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment.

9 COVID-19 - Considerations for the paediatric rheumatologist.

10 Early appearance of COVID-19 associated pulmonary infiltrates during daily radiotherapy imaging for lung cancer.

11 COVID-19 or Lung Cancer: what should we treat?

12 Mutated COVID-19, May Foretells Mankind in a Great Risk in the Future.

13 [Obstetric Anesthesia During the SARS-CoV-2 Pandemic - a Brief Overview of Published Recommendations for Action by National and International Specialist Societies and Committees].

14 High-Density Lipoprotein Nanobiologics for Precision Medicine.

15 [Infections which humans in the household transmit to dogs and cats].

16 Angiotensin-converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS-CoV-2: A double-edged sword?

17 Paediatric Anaesthetic implications of COVID-19 - A Review of Current Literature.

18 Eosinophil Responses During COVID-19 Infections and Coronavirus Vaccination.

19 Potential Factors Influencing Repeated SARS Outbreaks in China.

20 A pneumonia outbreak associated with a new coronavirus of probable bat origin.

21 Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies.

22 Anti COVID-19 Drugs: Need for More Clinical Evidence and Global Action.

23 A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2.

24 Clusters of Coronavirus Disease in Communities, Japan, January-April 2020.

25 Impact of COVID-19 public health interventions on influenza incidence in Thailand.

26 COVID-19: the great unequaliser.

27 COVID-19 in India.

28 Uncertainty and COVID-19: how are we to respond?

29 The primary care response to COVID-19 in England's National Health Service.

30 Anatomising failure: there should be a statutory public inquiry into the UK Government's handling of COVID-19.

31 The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?

32 Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses.

33 Letter in response to the article "Enhancing immunity in viral infections, with special emphasis on COVID-19: A review" (Jayawardena et al.).

34 síndrome respiratorio agudo grave: el laboratorio de salud pública frente a una emergencia global severe acute respiratory syndrome: the public health laboratory in a global emergency

35 becoming modern after sars. battling the h1n1 pandemic and the politics of backwardness in china′s pearl river delta

36 C-QSAR: a database of 18,000 QSARs and associated biological and physical data.

37 From SARS to MERS, Thrusting Coronaviruses into the Spotlight.

38 THE ORGANIZATION OF HOSPITAL CARE DURING THE EPIDEMIC OF INFLUENZA AND SARS FOR THE 2016 SEASON IN VELIKY NOVGOROD

39 LEGO-based generalized set of two linear algebraic 3D bio-macro-molecular descriptors: Theory and validation by QSARs.

40 Contested "Places" and conflicted nexuses in Gloria Naylor's Linden Hills and Mairuth Sarsfield's no crystal stair

41 Structural insights of a self-assembling 9-residue peptide from the C-terminal tail of the SARS corona virus E-protein in DPC and SDS micelles: A combined high and low resolution spectroscopic study

42 Challenges presented by MERS corona virus, and SARS corona virus to global health

43 Reference gene selection for quantitative real-time PCR analysis in virus infected cells: SARS corona virus, Yellow fever virus, Human Herpesvirus-6, Camelpox virus and Cytomegalovirus infections

44 LEGO-based generalized set of two linear algebraic 3D bio-macro-molecular descriptors: Theory and validation by QSARs.

45 Application of QSARs in identification of mutagenicity mechanisms of nitro and amino aromatic compounds against Salmonella typhimurium species

46 Ultra-High-Energy Cosmic-Ray Acceleration by Magnetic Reconnection in Newborn Accretion-induced Collapse Pulsars.

47 Low-frequency Faraday rotation measures towards pulsars using LOFAR: Probing the 3D Galactic halo magnetic field

48 A LOFAR search for steep-spectrum pulsars in supernova remnants and pulsar wind nebulae

49 Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.

50 Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity?

51 A doubt of multiple introduction of SARS-CoV-2 in Italy: a preliminary overview.

52 From SARS to COVID-19: A previously unknown SARS- related coronavirus (SARS-CoV-2) of pandemic potential infecting humans – Call for a One Health approach

53 Li Wenliang, a face to the frontline healthcare worker. The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak

54 The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines

55 Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV.

56 Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates.

57 Safety Considerations in the Laboratory Testing of Specimens Suspected or Known to Contain the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).

58 SARS-CoV-2 and COVID-19: The most important research questions.

59 Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations

60 The novel Coronavirus (SARS-CoV-2) is a one health issue

61 Enteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible?

62 Rapid random access detection of the novel SARS-coronavirus-2 (SARS-CoV-2, previously 2019-nCoV) using an open access protocol for the Panther Fusion

63 Peptide Mimicrying Between SARS Coronavirus Spike Protein and Human Proteins Reacts with SARS Patient Serum

64 Genetic Variation of SARS Coronavirus in Beijing Hospital

65 Characterization and inhibition of SARS-coronavirus main protease.

66 Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro.

67 Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs.

68 An Overview of Severe Acute Respiratory Syndrome--Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy

69 Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy.

70 Possible Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a Public Bath Center in Huai'an, Jiangsu Province, China.

71 Response to: Sore throat in COVID-19: comment on "Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis".

72 Identification of Chymotrypsin-like Protease Inhibitors of SARS-CoV-2 Integrated Computational Approach.

73 SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes.

74 Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection.

75 F-FDG uptake in Asymptomatic SARS-CoV-2 (COVID-19) patient, referred to PET/CT for Non-Small Cells Lung Cancer restaging.

76 Novel 2019 coronavirus SARS-CoV-2 (COVID-19): An updated overview for emergency clinicians

77 Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19).

78 The enlightenment from two cases of asymptomatic infection with SARS-CoV-2: is it safe after 14 days of isolation?

79 A first Case of Meningitis/Encephalitis associated with SARS-Coronavirus-2.

80 Severe Acute Respiratory Syndrome (SARS) and Coronavirus disease-2019 (COVID-19): From Causes to Preventions in Hong Kong.

81 The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro.

82 Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro.

83 Urgent need for individual mobile phone and institutional reporting of at home, hospitalized, and intensive care unit cases of SARS-CoV-2 (COVID-19) infection.

84 Nuclear medicine in SARS-CoV-2 pandemia: 18F-FDG-PET/CT to visualize COVID-19.

85 SARS-CoV-2 Vaccines: Status Report.

86 Infection and Rapid Transmission of SARS-CoV-2 in Ferrets.

87 Universal Screening for SARS-CoV-2 in Women Admitted for Delivery.

88 Stability and Viability of SARS-CoV-2. Reply.

89 Stability and Viability of SARS-CoV-2.

90 Stability and Viability of SARS-CoV-2.

91 Stability and Viability of SARS-CoV-2.

92 Stability and Viability of SARS-CoV-2.

93 Stability and Viability of SARS-CoV-2.

94 A field indoor air measurement of SARS-CoV-2 in the patient rooms of the largest hospital in Iran.

95 Mathematical model of infection kinetics and its analysis for COVID-19, SARS and MERS

96 Extreme genomic CpG deficiency in SARS-CoV-2 and evasion of host antiviral defense.

97 Clinical Trials during the SARS-CoV-2 Pandemic.

98 The evidence of SARS-CoV-2 infection on ocular surface.

99 Supporting pandemic response using genomics and bioinformatics: a case study on the emergent SARS-CoV-2 outbreak.

100 Advanced forecasting of SARS-CoV-2 related deaths in Italy, Germany, Spain, and New York State.

101 Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties.